These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 35777873)

  • 1. Effectiveness of the Med Safety mobile application in improving adverse drug reaction reporting by healthcare professionals in Uganda: a protocol for a pragmatic cluster-randomised controlled trial.
    Kiguba R; Mwebaza N; Ssenyonga R; Ndagije HB; Nambasa V; Katureebe C; Katumba K; Tregunno P; Harrison K; Karamagi C; Scott KA; Pirmohamed M
    BMJ Open; 2022 Jul; 12(7):e061725. PubMed ID: 35777873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implementation of a peer support intervention to promote the detection, reporting and management of adverse drug reactions in people living with HIV in Uganda: a protocol for a quasi-experimental study.
    Kiguba R; Ndagije HB; Nambasa V; Katureebe C; Zakumumpa H; Nanyonga SM; Ssanyu JN; Tregunno P; Harrison K; Merle CS; Raguenaud ME; Kitutu FE
    BMJ Open; 2022 May; 12(5):e056039. PubMed ID: 35589351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Facilitators and Barriers to Uptake of the Med Safety Mobile App for Adverse Drug Reaction Reporting by Health Workers in Uganda: A Qualitative Study.
    Kiguba R; Zakumumpa H; Ndagije HB; Mwebaza N; Ssenyonga R; Tregunno P; Harrison K; Pirmohamed M
    Drug Saf; 2023 Jun; 46(6):565-574. PubMed ID: 37097426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dedicated mobile application for drug adverse reaction reporting by patients with relapsing remitting multiple sclerosis (Vigip-SEP study): study protocol for a randomized controlled trial.
    Defer G; Le Caignec F; Fedrizzi S; Montastruc F; Chevanne D; Parienti JJ; Peyro-Saint-Paul L
    Trials; 2018 Mar; 19(1):174. PubMed ID: 29523169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decentralising chronic disease management in sub-Saharan Africa: a protocol for the qualitative process evaluation of community-based integrated management of HIV, diabetes and hypertension in Tanzania and Uganda.
    Van Hout MC; Akugizibwe M; Shayo EH; Namulundu M; Kasujja FX; Namakoola I; Birungi J; Okebe J; Murdoch J; Mfinanga SG; Jaffar S
    BMJ Open; 2024 Mar; 14(3):e078044. PubMed ID: 38508649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
    Akova M; Unal S
    Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recommendations on the Use of Mobile Applications for the Collection and Communication of Pharmaceutical Product Safety Information: Lessons from IMI WEB-RADR.
    Pierce CE; de Vries ST; Bodin-Parssinen S; Härmark L; Tregunno P; Lewis DJ; Maskell S; Van Eemeren R; Ptaszynska-Neophytou A; Newbould V; Dasgupta N; Wisniewski AFZ; Gama S; Mol PGM
    Drug Saf; 2019 Apr; 42(4):477-489. PubMed ID: 30911975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adverse drug reaction reporting among health care workers at Mulago National Referral and Teaching hospital in Uganda.
    Katusiime B; Semakula D; Lubinga SJ
    Afr Health Sci; 2015 Dec; 15(4):1308-17. PubMed ID: 26958036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protocol for the 3HP Options Trial: a hybrid type 3 implementation-effectiveness randomized trial of delivery strategies for short-course tuberculosis preventive therapy among people living with HIV in Uganda.
    Kadota JL; Musinguzi A; Nabunje J; Welishe F; Ssemata JL; Bishop O; Berger CA; Patel D; Sammann A; Katahoire A; Nahid P; Belknap R; Phillips PPJ; Namusobya J; Kamya M; Handley MA; Kiwanuka N; Katamba A; Dowdy D; Semitala FC; Cattamanchi A
    Implement Sci; 2020 Aug; 15(1):65. PubMed ID: 32787925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rationale and design of leveraging the HIV platform for hypertension control in Africa: protocol of a cluster-randomised controlled trial in Uganda.
    Atukunda M; Kabami J; Mutungi G; Twinamatsiko B; Nangendo J; Shade SB; Charlebois E; Grosskurth H; Kamya M; Okello E
    BMJ Open; 2022 Dec; 12(12):e063227. PubMed ID: 36600388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correction: Effectiveness of the med Safety mobile application in improving adverse drug reaction reporting by healthcare professionals in Uganda: a protocol for a pragmatic cluster-randomised controlled trial.
    BMJ Open; 2024 Jun; 14(6):e061725corr1. PubMed ID: 38890145
    [No Abstract]   [Full Text] [Related]  

  • 14. Trends in Adverse Event Reporting Before and After the Introduction of the Med Safety App in Nigeria.
    Elemuwa UG; Bitrus F; Oreagba IA; Osakwe AI; Abiodun AS; Onu K; Abubakar A; Faniyi AE; Etuk V; Yuah D; Momodu R; Adeyeye CM
    Pharmaceut Med; 2024 May; 38(3):251-259. PubMed ID: 38705932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reporting, Monitoring, and Handling of Adverse Drug Reactions in Australia: Scoping Review.
    Fossouo Tagne J; Yakob RA; Dang TH; Mcdonald R; Wickramasinghe N
    JMIR Public Health Surveill; 2023 Jan; 9():e40080. PubMed ID: 36645706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A user-centred implementation strategy for tuberculosis contact investigation in Uganda: protocol for a stepped-wedge, cluster-randomised trial.
    Katamba A; Gupta AJ; Turimumahoro P; Ochom E; Ggita JM; Nakasendwa S; Nanziri L; Musinguzi J; Hennein R; Sekadde M; Hanrahan C; Byaruhanga R; Yoeli E; Turyahabwe S; Cattamanchi A; Dowdy DW; Haberer JE; Armstrong-Hough M; Kiwanuka N; Davis JL
    BMC Public Health; 2023 Aug; 23(1):1568. PubMed ID: 37592314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Addressing the under-reporting of adverse drug reactions in public health programs controlling HIV/AIDS, Tuberculosis and Malaria: A prospective cohort study.
    Avong YK; Jatau B; Gurumnaan R; Danat N; Okuma J; Usman I; Mordi D; Ukpabi B; Kayode GA; Dutt S; El-Tayeb O; Afolabi B; Ambrose I; Agbaji O; Osakwe A; Ibrahim A; Ogar C; Nosiri H; Avong EB; Adekanmbi V; Uthman O; Abimiku A; Oni YO; Mensah CO; Dakum P; Mberu KE; Ogundahunsi OAT
    PLoS One; 2018; 13(8):e0200810. PubMed ID: 30133453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness of exercise referral schemes enhanced by self-management strategies to battle sedentary behaviour in older adults: protocol for an economic evaluation alongside the SITLESS three-armed pragmatic randomised controlled trial.
    Deidda M; Coll-Planas L; Giné-Garriga M; Guerra-Balic M; Roqué I Figuls M; Tully MA; Caserotti P; Rothenbacher D; Salvà Casanovas A; Kee F; Blackburn NE; Wilson JJ; Skjødt M; Denkinger M; Wirth K; McIntosh E;
    BMJ Open; 2018 Oct; 8(10):e022266. PubMed ID: 30327403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Active Pharmacovigilance Project on the safety profile of Dolutegravir in Brazil.
    Mendes JC; Ceccato MDGB; Reis AMM; Costa AMGD; Pantuzza LLN; Furtado Dos Santos S; Crepalde-Ribeiro K; Silveira MR
    AIDS Care; 2023 May; 35(5):729-738. PubMed ID: 35578399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Effect of Group Support Psychotherapy Delivered by Trained Lay Health Workers for Depression Treatment Among People with HIV in Uganda: Protocol of a Pragmatic, Cluster Randomized Trial.
    Nakimuli-Mpungu E; Musisi S; Wamala K; Okello J; Ndyanabangi S; Mojtabai R; Nachega J; Harari O; Mills E
    JMIR Res Protoc; 2017 Dec; 6(12):e250. PubMed ID: 29229589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.